Xenoestrogens alter estrogen receptor (ER) α intracellular levels

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  La Rosa, Piergiorgio ^a   Pellegrini, Marco ^a   Totta, Pierangela ^a   Acconcia, Filippo ^a   Marino, Maria ^a  

^a ROMA TRE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ENDOCRINE DISRUPTOR; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NARINGENIN; SYNAPTOPHYSIN; ANTIESTROGEN; BENZHYDRYL DERIVATIVE; ESTROGEN; FLAVANONE DERIVATIVE; LUCIFERASE; PHENOL DERIVATIVE; PRIMER DNA;

ARTICLE; BIOACCUMULATION; CANCER CELL CULTURE; CELL COUNT; CELL LOSS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; DRUG PROTEIN BINDING; DRUG TARGETING; ENZYME ACTIVATION; ERALPHA GENE; GENETIC TRANSCRIPTION; HORMONE PROTEIN COMPLEX; HUMAN; HUMAN CELL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; ANALYSIS OF VARIANCE; DOSE RESPONSE; DRUG EFFECTS; GENETICS; MCF 7 CELL LINE; METABOLISM; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANALYSIS OF VARIANCE; BENZHYDRYL COMPOUNDS; CELL PROLIFERATION; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCRINE DISRUPTORS; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; ESTROGENS, NON-STEROIDAL; FLAVANONES; HUMANS; LUCIFERASES; MCF-7 CELLS; PHENOLS; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

EID: 84897806631     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088961     Document Type: Article

References (26)

1. Ascenzi P, Bocedi A, Marino M (2006) Structure-function relationship of estrogen receptor a and b: impact on human health. Mol Aspects Med 27: 299-402. (Pubitemid 44255847)
2. Marino M, Pellegrini M, La Rosa P, Acconcia F (2012) Susceptibility of estrogen receptor rapid responses to xenoestrogens: Physiological outcomes. Steroids 77: 910-917.
3. Caiazza F, Galluzzo P, Lorenzetti S, Marino M (2007) 17β-estradiol induces ERβ up-regulation via p38/MAPK activation in colon cancer cells. Biochem Biophys Res Commun 359: 102-107. (Pubitemid 46839219)
4. La Rosa P, Pesiri V, Leclercq G, Marino M, Acconcia F (2012) Palmitoylation regulates 17β-estradiol-induced estrogen receptor-α degradation and transcriptional activity. Mol Endocrinol 26: 762-774.
5. Thomas C, Gustafsson JA (2011) The different roles of ER subtypes in cancer biology and therapy. Nat Rev Cancer 11: 597-608.
6. Roger P, Sahla ME, Makela S, Gustafsson JA, Baldet P, et al. (2001) Decreased expression of estrogen receptor βprotein in proliferative preinvasive mammary tumors. Cancer Res 61: 2537-2541. (Pubitemid 32685835)
7. Leclercq G, Lacroix M, Laios I, Laurent G (2006) Estrogen receptor α: impact of ligands on intracellular shuttling and turnover rate in breast cancer cells. Curr Cancer Drug Targets 6: 39-64.
8. Reid G, Hubner MR, Metivier R, Brand H, Denger S, et al. (2003) Cyclic, proteasome-mediated turnover of unliganded and liganded ERα on responsive promoters is an integral feature of estrogen signaling. Mol Cell 11: 695-707. (Pubitemid 36385123)
9. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, et al. (2009) Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev 30: 293-342.
10. Zoeller RT, Brown TR, Doan LL, Gore AC, Skakkebaek NE, et al. (2012) Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society. Endocrinology 153: 4097-4110.
11. Bolli A, Galluzzo P, Ascenzi P, Del Pozzo G, Manco I, et al. (2008) Laccase treatment impairs bisphenol A-induced cancer cell proliferation affecting estrogen receptor α-dependent rapid signals. IUBMB Life 60: 843-852.
12. Bulzomi P, Bolli A, Galluzzo P, Leone S, Acconcia F, et al. (2010) Naringenin and 17 β-estradiol coadministration prevents hormone-induced human cancer cell growth. IUBMB Life 62: 51-60.
13. Bulzomi P, Galluzzo P, Bolli A, Leone S, Acconcia F, et al. (2012) The proapoptotic effect of quercetin in cancer cell lines requires ER β-dependent signals. J Cell Physiol 227: 1891-1898.
14. Ali S, Metzger D, Bornert JM, Chambon P (1993) Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region. EMBO J 12: 1153-1160. (Pubitemid 23095864)
15. Galluzzo P, Ascenzi P, Bulzomi P, Marino M (2008) The nutritional flavanone naringenin triggers antiestrogenic effects by regulating estrogen receptor α-palmitoylation. Endocrinology 149: 2567-2575. (Pubitemid 351577394)
16. Totta P, Acconcia F, Leone S, Cardillo I, Marino M (2004) Mechanisms of naringenin-induced apoptotic cascade in cancer cells: Involvement of estrogen receptor α and β signalling. IUBMB Life 56: 491-499. (Pubitemid 39582784)
17. Acconcia F, Totta P, Ogawa S, Cardillo I, Inoue S, et al. (2005) Survival versus apoptotic 17beta-estradiol effect: role of ER alpha and ER beta activated non-genomic signaling. J Cell Physiol 203: 193-201. (Pubitemid 40330938)
18. Lange CA, Shen T, Horwitz KB (2000) Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. Proc Natl Acad Sci U S A 97: 1032-1037. (Pubitemid 30080807)
19. Manavathi B, Dey O, Gajulapalli VN, Bhatia RS, Bugide S, et al. (2012) Derailed Estrogen Signaling and Breast Cancer: An Authentic Couple. Endocr Rev 34: 1-32.
20. Li Y, Kong D, Wang Z, Sarkar FH (2010) Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research. Pharm Res 27: 1027-1041.
21. Bhatt S, Xiao Z, Meng Z, Katzenellenbogen BS (2012) Phosphorylation by p38 mitogen-activated protein kinase promotes estrogen receptor alpha turnover and functional activity via the SCF(Skp2) proteasomal complex. Mol Cell Biol 32: 1928-1943.
22. Lee H, Bai W (2002) Regulation of estrogen receptor nuclear export by ligandinduced and p38-mediated receptor phosphorylation. Mol Cell Biol 22: 5835-5845. (Pubitemid 34815832)
23. Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR Jr, et al. (2012) Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev 33: 378-455.
24. Bolli A, Bulzomi P, Galluzzo P, Acconcia F, Marino M (2010) Bisphenol A Impairs Estradiol-induced Protective Effects Against DLD-1 Colon Cancer Cell Growth. IUBMB Life 62: 684-687.
25. Bulzomi P, Bolli A, Galluzzo P, Acconcia F, Ascenzi P, et al. (2012) The naringenin-induced proapoptotic effect in breast cancer cell lines holds out against a high bisphenol a background. IUBMB Life 64: 690-696.
26. Matthews J, Gustafsson JA (2003) Estrogen signaling: a subtle balance between ER α and ER β. Mol Interv 3: 281-292.